Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2016

Mar 4, 2016

32227_dirs_2016-03-04_22a99648-4bf7-47ca-9d5e-26b0de98abd9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-03-03

Reporting Person: HANNAH ALISON L. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-03 Common stock P 10000 $6.90 Acquired 11560 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $6.66 2020-07-15 Common Stock (10000) 10000 Direct

Footnotes

F1: On July 15, 2015 Alison Hannah was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.